Liana K Billings et al, Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial, The Lancet, 2025, Kirsten Dahl et al, NN1213-A Potent, Long-Acting, and Selective Analog of Human Amylin, J
Using degraded copper peptides wastes time and provides false hope
6 De VendittisA.MarcoS.Di MaroA.ChamberyA.AlbinoA.MasulloM.et al (2012)
For people who experience vitamin B12 deficiency, they can be a critical source of this essential vitamin the body needs to generate energy
Eur J Biochem 133:5169
Healthcare providers and patients who suspect an adverse reaction to tirzepatide should report it to the FDA MedWatch program